IQVIA HOLDINGS INC. Other Nonoperating Income (Expense)
IQVIA HOLDINGS INC. (IQV) reported Other Nonoperating Income (Expense) of -$4.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-05-05
- IQVIA HOLDINGS INC. other nonoperating income (expense) for the quarter ending 2026-03-31 was -$4.00M.
- IQVIA HOLDINGS INC. other nonoperating income (expense) for the quarter ending 2025-12-31 was $94.00M, a 20.51% increase year-over-year.
- IQVIA HOLDINGS INC. other nonoperating income (expense) for the quarter ending 2025-09-30 was $31.00M.
- IQVIA HOLDINGS INC. other nonoperating income (expense) for the quarter ending 2025-06-30 was -$11.00M, a 116.42% decline year-over-year.
- IQVIA HOLDINGS INC. other nonoperating income (expense) for fiscal 2025 was $99.00M, a 10.00% increase from fiscal 2024.
- IQVIA HOLDINGS INC. other nonoperating income (expense) for fiscal 2024 was $90.00M, a 27.42% decline from fiscal 2023.
- IQVIA HOLDINGS INC. other nonoperating income (expense) for fiscal 2023 was $124.00M.
- IQVIA HOLDINGS INC. other nonoperating income (expense) for fiscal 2022 was -$33.00M, a 125.38% decline from fiscal 2021.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$4.00M 10-Q · filed 2026-05-05 | $90.00M derived: sum of 2 quarters · filed 2026-05-05 | $121.00M derived: sum of 3 quarters · filed 2026-05-05 | $110.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2025-12-31 | $94.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $125.00M derived: sum of 2 quarters · filed 2026-02-17 | $114.00M derived: sum of 3 quarters · filed 2026-02-17 | $99.00M 10-K · filed 2026-02-17 | ||||
| 2025-09-30 | $31.00M 10-Q · filed 2025-10-28 | $20.00M derived: sum of 2 quarters · filed 2025-10-28 | $5.00M 10-Q · filed 2025-10-28 | $83.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2025-06-30 | -$11.00M 10-Q · filed 2025-07-22 | -$26.00M 10-Q · filed 2025-07-22 | $52.00M derived: sum of 3 quarters · filed 2026-05-05 | $8.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2025-03-31 | -$15.00M 10-Q · filed 2026-05-05 | $63.00M derived: sum of 2 quarters · filed 2026-05-05 | $19.00M derived: sum of 3 quarters · filed 2026-05-05 | $86.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $78.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $34.00M derived: sum of 2 quarters · filed 2026-02-17 | $101.00M derived: sum of 3 quarters · filed 2026-02-17 | $90.00M 10-K · filed 2026-02-17 | ||||
| 2024-09-30 | -$44.00M 10-Q · filed 2025-10-28 | $23.00M derived: sum of 2 quarters · filed 2025-10-28 | $12.00M 10-Q · filed 2025-10-28 | $59.00M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-06-30 | $67.00M 10-Q · filed 2025-07-22 | $56.00M 10-Q · filed 2025-07-22 | $103.00M derived: sum of 3 quarters · filed 2026-02-17 | $138.00M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-03-31 | -$11.00M 10-Q · filed 2025-05-06 | $36.00M derived: sum of 2 quarters · filed 2026-02-17 | $71.00M derived: sum of 3 quarters · filed 2026-02-17 | $87.00M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2023-12-31 | $47.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $82.00M derived: sum of 2 quarters · filed 2026-02-17 | $98.00M derived: sum of 3 quarters · filed 2026-02-17 | $124.00M 10-K · filed 2026-02-17 | ||||
| 2023-09-30 | $35.00M 10-Q · filed 2024-10-31 | $51.00M derived: sum of 2 quarters · filed 2024-10-31 | $77.00M 10-Q · filed 2024-10-31 | $95.00M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $16.00M 10-Q · filed 2024-07-22 | $42.00M 10-Q · filed 2024-07-22 | $60.00M derived: sum of 3 quarters · filed 2025-02-13 | $52.00M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | $26.00M 10-Q · filed 2024-05-02 | $44.00M derived: sum of 2 quarters · filed 2025-02-13 | $36.00M derived: sum of 3 quarters · filed 2025-02-13 | $3.00M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | $18.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $10.00M derived: sum of 2 quarters · filed 2025-02-13 | -$23.00M derived: sum of 3 quarters · filed 2025-02-13 | -$33.00M 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | -$8.00M 10-Q · filed 2023-11-01 | -$41.00M derived: sum of 2 quarters · filed 2023-11-01 | -$51.00M 10-Q · filed 2023-11-01 | -$49.00M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | -$33.00M 10-Q · filed 2023-08-01 | -$43.00M 10-Q · filed 2023-08-01 | -$41.00M derived: sum of 3 quarters · filed 2024-02-15 | $21.00M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | -$10.00M 10-Q · filed 2023-04-28 | -$8.00M derived: sum of 2 quarters · filed 2024-02-15 | $54.00M derived: sum of 3 quarters · filed 2024-02-15 | $83.00M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $64.00M derived: sum of 2 quarters · filed 2024-02-15 | $93.00M derived: sum of 3 quarters · filed 2024-02-15 | $130.00M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $62.00M 10-Q · filed 2022-10-27 | $91.00M derived: sum of 2 quarters · filed 2022-10-27 | $128.00M 10-Q · filed 2022-10-27 | $134.00M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | $29.00M 10-Q · filed 2022-07-22 | $66.00M 10-Q · filed 2022-07-22 | $72.00M derived: sum of 3 quarters · filed 2023-02-15 | $86.00M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | $37.00M 10-Q · filed 2022-04-28 | $43.00M derived: sum of 2 quarters · filed 2023-02-15 | $57.00M derived: sum of 3 quarters · filed 2023-02-15 | $89.00M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $20.00M derived: sum of 2 quarters · filed 2023-02-15 | $52.00M derived: sum of 3 quarters · filed 2023-02-15 | $65.00M 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | $14.00M 10-Q · filed 2021-10-22 | $46.00M derived: sum of 2 quarters · filed 2021-10-22 | $59.00M 10-Q · filed 2021-10-22 | $96.00M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-06-30 | $32.00M 10-Q · filed 2021-07-28 | $45.00M 10-Q · filed 2021-07-28 | $82.00M derived: sum of 3 quarters · filed 2022-02-16 | $82.00M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-03-31 | $13.00M 10-Q · filed 2021-04-23 | $50.00M derived: sum of 2 quarters · filed 2022-02-16 | $50.00M derived: sum of 3 quarters · filed 2022-02-16 | $43.00M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2019-12-31 | $37.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $37.00M derived: sum of 2 quarters · filed 2022-02-16 | $30.00M derived: sum of 3 quarters · filed 2022-02-16 | $37.00M 10-K · filed 2022-02-16 | ||||
| 2019-09-30 | $0.00 10-Q · filed 2020-10-22 | -$7.00M derived: sum of 2 quarters · filed 2020-10-22 | $0.00 10-Q · filed 2020-10-22 | $0.00 derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-06-30 | -$7.00M 10-Q · filed 2020-07-23 | $0.00 10-Q · filed 2020-07-23 | $0.00 derived: sum of 3 quarters · filed 2021-02-12 | -$27.00M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-03-31 | $7.00M 10-Q · filed 2020-04-30 | $7.00M derived: sum of 2 quarters · filed 2021-02-12 | -$20.00M derived: sum of 3 quarters · filed 2021-02-12 | $6.00M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | -$27.00M derived: sum of 2 quarters · filed 2021-02-12 | -$1.00M derived: sum of 3 quarters · filed 2021-02-12 | -$5.00M 10-K · filed 2021-02-12 | ||||
| 2018-09-30 | -$27.00M 10-Q · filed 2019-11-01 | -$1.00M derived: sum of 2 quarters · filed 2019-11-01 | -$5.00M 10-Q · filed 2019-11-01 | -$21.00M derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-06-30 | $26.00M 10-Q · filed 2019-07-24 | $22.00M 10-Q · filed 2019-07-24 | $6.00M derived: sum of 3 quarters · filed 2020-02-18 | $3.00M derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-03-31 | -$4.00M 10-Q · filed 2019-05-02 | -$20.00M derived: sum of 2 quarters · filed 2020-02-18 | -$23.00M derived: sum of 3 quarters · filed 2020-02-18 | -$21.00M derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2017-12-31 | -$16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | -$19.00M derived: sum of 2 quarters · filed 2020-02-18 | -$17.00M derived: sum of 3 quarters · filed 2020-02-18 | -$13.00M 10-K · filed 2020-02-18 | -$30.00M 10-K · filed 2018-02-16 | |||
| 2017-09-30 | -$3.00M 10-Q · filed 2017-10-27 | -$1.00M derived: sum of 2 quarters · filed 2018-07-27 | $3.00M 10-Q · filed 2018-10-25 | -$9.00M 10-Q · filed 2017-10-27 | $14.00M derived: sum of 4 quarters · filed 2019-02-19 | |||
| 2017-06-30 | $2.00M 10-Q · filed 2018-07-27 | -$3.00M 10-Q · filed 2017-08-04 | $3.00M 10-Q · filed 2018-07-27 | -$6.00M 10-Q · filed 2017-08-04 | $17.00M derived: sum of 3 quarters · filed 2019-02-19 | $16.00M derived: sum of 4 quarters · filed 2019-02-19 | ||
| 2017-03-31 | $1.00M 10-Q · filed 2018-05-04 | -$3.00M 10-Q · filed 2017-05-08 | $15.00M derived: sum of 2 quarters · filed 2019-02-19 | $14.00M derived: sum of 3 quarters · filed 2019-02-19 | $17.00M derived: sum of 4 quarters · filed 2019-02-19 | |||
| 2016-12-31 | $14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $13.00M derived: sum of 2 quarters · filed 2019-02-19 | $16.00M derived: sum of 3 quarters · filed 2019-02-19 | $11.00M 10-K · filed 2019-02-19 | $8.00M 10-K · filed 2017-02-16 | |||
| 2016-09-30 | -$1.00M 10-Q · filed 2017-10-27 | -$1.67M 10-Q · filed 2016-11-03 | $2.00M derived: sum of 2 quarters · filed 2017-10-27 | -$3.00M 10-Q · filed 2017-10-27 | -$3.37M 10-Q · filed 2016-11-03 | $2.86M derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-06-30 | $3.00M 10-Q · filed 2017-08-04 | $2.80M 10-Q · filed 2016-07-27 | -$2.00M 10-Q · filed 2017-08-04 | -$1.70M 10-Q · filed 2016-07-27 | $3.86M derived: sum of 3 quarters · filed 2018-02-16 | $4.80M derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-03-31 | -$5.00M 10-Q · filed 2017-05-08 | -$4.51M 10-Q · filed 2016-05-03 | $864.00K derived: sum of 2 quarters · filed 2018-02-16 | $1.80M derived: sum of 3 quarters · filed 2018-02-16 | -$9.86M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2015-12-31 | $5.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $6.80M derived: sum of 2 quarters · filed 2018-02-16 | -$4.86M derived: sum of 3 quarters · filed 2018-02-16 | -$2.00M 10-K · filed 2018-02-16 | -$2.36M 10-K · filed 2016-02-11 | |||
| 2015-09-30 | $934.00K 10-Q · filed 2016-11-03 | -$10.72M derived: sum of 2 quarters · filed 2016-11-03 | -$7.86M 10-Q · filed 2016-11-03 | -$9.43M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-06-30 | -$11.66M 10-Q · filed 2016-07-27 | -$8.80M 10-Q · filed 2016-07-27 | -$10.36M derived: sum of 3 quarters · filed 2017-02-16 | -$2.59M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-03-31 | $2.86M 10-Q · filed 2016-05-03 | $1.30M derived: sum of 2 quarters · filed 2017-02-16 | $9.07M derived: sum of 3 quarters · filed 2017-02-16 | $6.02M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2014-12-31 | -$1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $6.21M derived: sum of 2 quarters · filed 2017-02-16 | $3.16M derived: sum of 3 quarters · filed 2017-02-16 | $8.00M 10-K · filed 2017-02-16 | $8.98M 10-K · filed 2015-02-12 | |||
| 2014-09-30 | $7.78M 10-Q · filed 2015-10-28 | $4.72M derived: sum of 2 quarters · filed 2015-10-28 | $9.56M 10-Q · filed 2015-10-28 | $11.13M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-06-30 | -$3.06M 10-Q · filed 2015-07-29 | $1.79M 10-Q · filed 2015-07-29 | $3.35M derived: sum of 3 quarters · filed 2016-02-11 | $127.00K derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-03-31 | $4.84M 10-Q · filed 2015-04-29 | $6.41M derived: sum of 2 quarters · filed 2016-02-11 | $3.18M derived: sum of 3 quarters · filed 2016-02-11 | $2.65M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2013-12-31 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | -$1.66M derived: sum of 2 quarters · filed 2016-02-11 | -$2.20M derived: sum of 3 quarters · filed 2016-02-11 | $185.00K 10-K · filed 2016-02-11 | ||||
| 2013-09-30 | -$3.22M 10-Q · filed 2014-10-30 | -$3.76M derived: sum of 2 quarters · filed 2014-10-30 | -$1.38M 10-Q · filed 2014-10-30 | -$2.53M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-06-30 | -$536.00K 10-Q · filed 2014-07-31 | $1.85M 10-Q · filed 2014-07-31 | $690.00K derived: sum of 3 quarters · filed 2015-02-12 | -$3.16M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-03-31 | $2.38M 10-Q · filed 2014-05-01 | $1.23M derived: sum of 2 quarters · filed 2015-02-12 | -$2.62M derived: sum of 3 quarters · filed 2015-02-12 | $3.54M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2012-12-31 | -$1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | -$5.01M derived: sum of 2 quarters · filed 2015-02-12 | $1.15M derived: sum of 3 quarters · filed 2015-02-12 | $3.57M 10-K · filed 2015-02-12 | ||||
| 2012-09-30 | -$3.85M 10-Q · filed 2013-10-31 | $2.31M derived: sum of 2 quarters · filed 2013-10-31 | $4.73M 10-Q · filed 2013-10-31 | |||||
| 2012-06-30 | $6.16M 10-Q · filed 2013-08-01 | $8.58M 10-Q · filed 2013-08-01 | ||||||
| 2012-03-31 | $2.42M 10-Q · filed 2013-05-14 | |||||||
| 2011-12-31 | -$9.07M 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |